| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13G/A |
| 13 Nov 2026 | 144/A |
| 12 Nov 2026 | 144 |
| 10 Nov 2026 | 6-K |
| 05 Nov 2026 | SCHEDULE 13G/A |
| 04 Nov 2026 |
Form 4: Murray Ciaran, Director
Sold 3,452 shares ($710K) |
| 03 Nov 2026 |
Form 4: Balfe Barry Edward, Director
Received 9,662 shares by exercise or conversion · Sold 5,175 shares ($1.07M) |
| 03 Nov 2026 |
Form 4: Lyons Emer, Chief Accounting Officer
Received 491 shares by exercise or conversion · Sold 264 shares ($54.6K) |
| 03 Nov 2026 |
Form 4: Clerkin Nigel Bernard John, Chief Financial Officer
Received 2,778 shares by exercise or conversion · Sold 1,488 shares ($308K) |
| 02 Nov 2026 | 144 |
| 02 Nov 2026 | 144 |
| 02 Nov 2026 | 144 |
| 27 Oct 2026 | 6-K |
| 27 Oct 2026 | 6-K |
| 26 Oct 2026 |
Form 4: Lyons Emer, Chief Accounting Officer
Received 510 shares by exercise or conversion · Sold 272 shares ($49.6K) |
| 08 Oct 2026 | 6-K |
| 18 Sep 2026 |
Form 4: Climax John Dr, Director
Received 5,005 shares by exercise or conversion ($629K) · Sold 5,005 shares ($876K) |
| 18 Sep 2026 |
Form 4: McCague Eugene Pacelli, Director
Received 3,255 shares by exercise or conversion ($409K) · Sold 3,255 shares ($570K) |
| 18 Sep 2026 |
Form 4: Murphy Ronan Martin, Director
Received 5,005 shares by exercise or conversion ($629K) · Sold 5,005 shares ($876K) |
| 17 Sep 2026 | 144 |
Loading...